Title : Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.

Pub. Date : 2021

PMID : 34473771






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. nafamostat nuclear factor kappa B subunit 1 Homo sapiens
2 The synthetic protease inhibitor nafamostat mesilate (NM) inhibits NF-kappaB activity and exerts antitumor actions in various types of cancer. nafamostat nuclear factor kappa B subunit 1 Homo sapiens
3 The synthetic protease inhibitor nafamostat mesilate (NM) inhibits NF-kappaB activity and exerts antitumor actions in various types of cancer. nafamostat nuclear factor kappa B subunit 1 Homo sapiens
4 Overall, NM enhanced the antitumor action of radiotherapy on GBC cells by suppressing radiation-induced NF-kappaB activity. nafamostat nuclear factor kappa B subunit 1 Homo sapiens